CD38-Targeted 89Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Gary A. Ulaner; Jason Lewis; Ola Landgren

doi:10.2967/jnumed.124.269393

Research ArticleThe Illustrated Post

CD38-Targeted ⁸⁹Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Gary A. Ulaner, Jason Lewis and Ola Landgren

Journal of Nuclear Medicine January 2025, jnumed.124.269393; DOI: https://doi.org/10.2967/jnumed.124.269393

Gary A. Ulaner

1Molecular Imaging and Therapy, Hoag Family Cancer Institute, Irvine, California;

2Radiology and Translational Genomics, University of Southern California, Los Angeles, California;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jason Lewis

3Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ola Landgren

4Division of Myeloma, University of Miami, Miami, Florida

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

Article Information

jnumed.124.269393

DOI

https://doi.org/10.2967/jnumed.124.269393

PubMed

39884767

Published By

Society of Nuclear Medicine

Print ISSN

0161-5505

Online ISSN

2159-662X

History

Received for publication December 18, 2024
Accepted for publication January 6, 2025
Published online January 30, 2025.

Article Versions

You are currently viewing a previous version of this article (January 30, 2025 - 06:58).
View the most recent version of this article

Author Information

Statistics from Altmetric.com

Cited By...

1 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Theranostics in Hematological Malignancies: Cutting-Edge Advances in Diagnosis and Targeted Therapy

Bojana Bogdanovic, Florent Hugonnet, Christopher Montemagno

Cancers 2025 17 7

Article usage

Article usage: January 2025 to April 2025

	Full	Pdf
Jan 2025	5	2
Feb 2025	31	41
Mar 2025	365	105
Apr 2025	121	75

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following CD38-Targeted 89Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

CD38-Targeted ⁸⁹Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Gary A. Ulaner, Jason Lewis, Ola Landgren

Journal of Nuclear Medicine Jan 2025, jnumed.124.269393; DOI: 10.2967/jnumed.124.269393

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

CD38-Targeted ⁸⁹Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Gary A. Ulaner, Jason Lewis, Ola Landgren

Journal of Nuclear Medicine Jan 2025, jnumed.124.269393; DOI: 10.2967/jnumed.124.269393

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

CD38-Targeted ⁸⁹Zr-DFO-Daratumumab PET of Myeloma: Immuno-PET Impacting Clinical Care

Article Information

Article Versions

Author Information

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: January 2025 to April 2025

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles